Global Lysine Crotonylation and 2-Hydroxyisobutyrylation in Phenotypically Different Toxoplasma gondii Parasites
- PMID: 31488510
- PMCID: PMC6823851
- DOI: 10.1074/mcp.RA119.001611
Global Lysine Crotonylation and 2-Hydroxyisobutyrylation in Phenotypically Different Toxoplasma gondii Parasites
Abstract
Toxoplasma gondii is a unicellular protozoan parasite of the phylum Apicomplexa. The parasite repeatedly goes through a cycle of invasion, division and induction of host cell rupture, which is an obligatory process for proliferation inside warm-blooded animals. It is known that the biology of the parasite is controlled by a variety of mechanisms ranging from genomic to epigenetic to transcriptional regulation. In this study, we investigated the global protein posttranslational lysine crotonylation and 2-hydroxyisobutyrylation of two T. gondii strains, RH and ME49, which represent distinct phenotypes for proliferation and pathogenicity in the host. Proteins with differential expression and modification patterns associated with parasite phenotypes were identified. Many proteins in T. gondii were crotonylated and 2-hydroxyisobutyrylated, and they were localized in diverse subcellular compartments involved in a wide variety of cellular functions such as motility, host invasion, metabolism and epigenetic gene regulation. These findings suggest that lysine crotonylation and 2-hydroxyisobutyrylation are ubiquitous throughout the T. gondii proteome, regulating critical functions of the modified proteins. These data provide a basis for identifying important proteins associated with parasite development and pathogenicity.
Keywords: Parasite; Toxoplasma gondii; pathway analysis; phenotype; posttranslational modification; protein-protein interactions; proteogenomics; proteome; regulation; virulence.
© 2019 Yin et al.
Figures








References
-
- Marino N. D., Panas M. W., Franco M., Theisen T. C., Naor A., Rastogi S., Buchholz K. R., Lorenzi H. A., and Boothroyd J. C. (2018) Identification of a novel protein complex essential for effector translocation across the parasitophorous vacuole membrane of Toxoplasma gondii. PLoS Pathog. 14, e1006828. - PMC - PubMed
-
- Kwong W. K., del Campo J., Mathur V., Vermeij M. J. A., and Keeling P. J. (2019) A widespread coral-infecting apicomplexan with chlorophyll biosynthesis genes. Nature 568, 103–107 - PubMed
-
- Pappas G., Roussos N., and Falagas M. E. (2009) Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int. J. Parasitol. 39, 1385–1394 - PubMed
-
- Valentini P., Buonsenso D., Barone G., Serranti D., Calzedda R., Ceccarelli M., Speziale D., Ricci R., and Masini L. (2015) Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy. J. Perinatol. 35, 90–94 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases